Search
for
Sort by
Research 30 of 1000+
- Controversy: Synthetic hairs and their role in hair restoration?
- View Point- Synthetic hairs: Should they be used?
- Synthetic Hairs: Their Role in Hair Restoration
- Arterielles popliteales Entrapment Syndrom (PAES) — ein Fallbericht zur Differentialdiagnose der Claudicatio intermittens
- Artificial Hair: By the Dawn to Automatic Biofibre® Hair Implant
- Artificial hair implantation for hair restoration
- Drugs that affect autonomic functions or the extrapyramidal system
- Current Status of Hair Restoration Surgery
- Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
- The Efficacy of Baricitinib as a Treatment Option for Alopecia, In Terms of Promoting Hair Regrowth and Improving Patient Reported Outcomes
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists
- Novel acne cream seeks FDA approval
- A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection
- Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study
- Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy
- The Use of Neurotoxins in the Male Face
- Practical Geriatrics: Maintaining Sexual Health After Menopause
- Androgenetic alopecia (male pattern hair loss) in the United States: What treatments should primary care providers recommend?
- Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
- Hair Care Cosmetics Regulation in Different Countries – A Comparative Study
- Testosterone Therapy in Women: A Literature Review of Clinical Indications, Dosing, Routes of Administration, and Safety
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Simultaneous spectrophotometric determination of finasteride and tadalafil in recently FDA approved Entadfi™ capsules
- Male Androgenetic Alopecia - A Review of Current Treatments
- Development of validated methods for the simultaneous quantification of Finasteride and Tadalafil in newly launched FDA-approved therapeutic combination: greenness assessment using AGP, analytical eco-scale, and GAPI tools